Fulltext

Cell-Free Microfluidic Determination of P-glycoprotein Interactions with Substrates and Inhibitors

Eyer, Klaus ; Herger, Michael ; Krämer, Stefanie ; Dittrich, Petra

In: Pharmaceutical Research, 2014, vol. 31, no. 12, p. 3415-3425

Zum persönliche Liste hinzufügen
    Titel
    • Cell-Free Microfluidic Determination of P-glycoprotein Interactions with Substrates and Inhibitors
    Autor
    • Eyer, Klaus. ETH Zurich, Department of Chemistry and Applied Biosciences, Bioanalytics, Laboratory of Organic Chemistry, Wolfgang-Pauli-Str. 10, 8093, Zurich, Switzerland
    • Herger, Michael. ETH Zurich, Department of Chemistry and Applied Biosciences, Bioanalytics, Laboratory of Organic Chemistry, Wolfgang-Pauli-Str. 10, 8093, Zurich, Switzerland
    • Krämer, Stefanie. ETH Zurich, Department of Chemistry and Applied Biosciences Biopharmacy and Radiopharmaceutical Sciences, Institute of Pharmaceutical Sciences,, 8093, Zurich, Switzerland
    • Dittrich, Petra. ETH Zurich, Department of Chemistry and Applied Biosciences, Bioanalytics, Laboratory of Organic Chemistry, Wolfgang-Pauli-Str. 10, 8093, Zurich, Switzerland
    Dokumententyp
    • Postprint
    Sprache
    • Englisch
    Veröffentlicht in
    • Pharmaceutical Research, 2014, vol. 31, no. 12, p. 3415-3425. Springer US; http://www.springer-ny.com
    Andere elektronische Ausgabe
    OAI-PMH-ID
    • oai:doc.rero.ch:325829
    Summary
    ABSTRACT: The membrane protein P-glycoprotein (P-gp) plays key roles in the oral bioavailability of drugs, their blood brain barrier passage as well as in multidrug resistance. For new drug candidates it is mandatory to study their interaction with P-gp, according to FDA and EMA regulations. The vast majority of these tests are performed using confluent cell layers of P-gp overexpressing cell lines that render these tests laborious. In this study, we introduce a cell-free microfluidic assay for the rapid testing of drug- P-gp interactions. Cell-derived vesicles are prepared from MDCKII-MDR1 overexpressing cells and immobilized on the surface of a planar microfluidic device. The drug is delivered continuously to the vesicles and calcein accumulation is monitored by means of a fluorescence assay and total internal reflection fluorescence (TIRF) microscopy. Only small amounts of compounds (~10μl) are required in concentrations of 5, 25 and 50μM for a test that provides within 5min information on the apparent dissociation constant of the drug and P-gp. We tested 10 drugs on-chip, 9 of which are inhibitors or substrates of P-glycoprotein and one negative control. We benchmarked the measured apparent dissociation constants against an alternative assay on a plate reader and reference data from FDA. These comparisons revealed good correlations between the logarithmic apparent dissociation constants (R2 = 0.95 with ATPase assay, R2 = 0.93 with FDA data) and show the reliability of the rapid on-chip test. The herein presented assay has an excellent screening window factor (Z'-factor) of 0.8, and is suitable for high-throughput testing.